Vimarsana
Biggest News Aggregation in the World

Page 31 - John Laing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Laing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Laing Today - Breaking & Trending Today

FTSE 100 in the red; Stronger start for US stocks - Vimarsana News

FTSE 100 in the red; Stronger start for US stocks

The UK blue chip index is virtually flat but Dow moves higher on its 125th anniversary

FTSE 100 in the red - just - while AstraZeneca PLC slips as EU court case begins - Vimarsana News

FTSE 100 in the red - just - while AstraZeneca PLC slips as EU court case begins

The UK's top share index finished a shade down at 7,026, off by nearly three points, or 0.04%

Vectura Group plc deal suggests plenty private equity takeover pipeline remains healthy - Vimarsana News

Vectura Group plc deal suggests plenty private equity takeover pipeline remains healthy

The number of private equity takeovers since the start of last year is now 124

FTSE 100 edges higher; Marks receives benefit of the doubt, while Vectura succumbs to private equity bid - Vimarsana News

FTSE 100 edges higher; Marks receives benefit of the doubt, while Vectura succumbs to private equity bid

FTSE 100 closes a shade lower on quiet news day The UK's top share index finished a shade down at 7,026, off by nearly three points, or 0.04% FTSE 100 closes a shade lower US stocks muted but higher Vectura receives bid 5pm: FTSE 100 closes slightly in the red FTSE 100 index closed near flat on Wednesday as there were few catalysts to excite investors. The UK's top share index finished a shade down at 7,026, off by nearly three points, or 0.04%. Meanwhile, the midcap FTSE 250 went higher, ending the midweek session up over 201 points, or 0.90%, at 22,640. "Weaker bank stocks have dragged the...

UK pharmaceutical firm Ventura agrees to £958m takeover deal - Vimarsana News

UK pharmaceutical firm Ventura agrees to £958m takeover deal

First published on Wed 26 May 2021 07.03 EDT Two British healthcare companies have been snapped up in deals worth a combined £2bn. The British pharmaceutical company Vectura Group, which is developing a pioneering inhaled treatment for Covid-19, has agreed a £958m takeover by Carlyle Group and looks likely to become the latest in a long line of UK businesses snapped up by private equity during the pandemic. Also on Wednesday, the private hospitals group Spire accepted a £1bn bid from Australia’s Ramsay Health Care. That offer was a near 25% premium on Spire’s previous closi...